Jacobi, Annett Marita: Zur Bedeutung des Prolaktins für Pathogenese und Krankheitsverlauf bei systemischem Lupus erythematodes (SLE)

86

Literatur

1. Munves EF, Schur PH. "Autoantibodies to Sm and RNP. Prognosticators of disease involvement. " Arthritis Rheum. 1983; 26: 848 - 53.

2. Smith HR, Steinberg AD. "Autoimmunity - a perspective. " Ann Rev Immunol. 1983; 1: 175 - 210.

3. Kunkel HG, Tan EM. "Autoantibody and disease. " Adv Immunol. 1964; 4: 351 - 95.

4. Fauci AS, Steinberg AD, Haynes BF, Wahlen G. "Immunoregulatory aberrations in systemic lupus erythematosus. " J Immunol. 1978; 121: 1473 - 9.

5. Hughes GRV. "Autoantibodies in lupus and its variants: experience in 1000 patients. " Br Med J. 1984; 289: 339 - 42.

6. Tan EM. "Antinuclear antibodies: diagnostic markers of autoimmune diseases and probes for cell biology. " Adv Immunol. 1989; 4: 93 - 151.

7. Klinman DM, Steinberg AD. "Systemic autoimmune disease arises from polyclonal B cell activation. " J Exp Med. 1987; 165: 1755 - 60.

8. Sakane T, Suzuki S, Takada Y, Ueda Y, Murkawa T, Tsuchida Y, Yamauchi Y, Kishimoto T. "B cell hyperactivity and its relation to distinct clinical features and the degree of disease activity in patients with systemic lupus erythematosus. " Arthritis Rheum. 1988; 31: 80 - 7.

9. Becker TM, Lizzo EF, Merchant LP, Reeves JP, Steinberg AD. "Increased multiclonal antibody-forming cell activation in the peripheral blood of patients with SLE. " Int Arch Allerg Appl Immunol. 1981; 66: 293 - 303.

10. Blaese RM, Grayson J, Steinberg AD. "Elevated immunoglobulin secreting cells in the blood of patients with active systemic lupus erythematosus: correlation of laboratory and clinical assessment of disease activity. " Am J Med. 1980; 69: 345 - 50.

11. Tan PLJ, Pang GTM, Wilson JD, Cullinane G. "Immunoglobulin secreting cells in SLE: correlation with disease activity. " J Rheumatol. 1980; 7: 807 - 13.

12. Al-Janadi M, Raziuddin S. "B cell hyperactivity is a function of T cell derived "


87

"cytokines in systemic lupus erythematosus. " J Rheumatol. 1993; 20: 1885 - 91.

13. Linker-Israeli M, Deans R. "Dysregulated lymphokine production in systemic lupus erythematosus. " Ann NY Acad Sci. 1989; 557: 567 -9.

14. Alcocer-Varela J, Alarcon´-Segovia D. "Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. " J Clin Invest. 1982; 69: 1388 - 92.

15. de Waal Melefyt R, Yssel H, de Vries. "Direct effect of IL-10 on subsets of human CD4+ T cells clones and resting T cells. Specic inhibition of IL-2 production and proliferation. " J Immunol. 1993; 150: 4754 - 65.

16. Llorente L, Richaud-Patin Y, Wijdenes J et al. "Spontaneous production of Interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. " Eur Cytokine Netw. 1993; 4: 421 - 30.

17. Kitani A, Hara M, Hirose M et al. "Autostimulatory effects of IL-6 on exessive B cell differetiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. " Clin exp Immunol. 1992; 88: 75 - 83.

18. Hagiwara E, Gourley MF, Lee S, Klinman DM. "Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of Interleukin-10: Interferon-gamma-secreting cells in the peripheral blood. " Arthitis Rheum. 1996; 39: 379 - 85.

19. Mossman TR, Coffman RL. "TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. " Ann Rev Immunol. 1989; 7: 145 -73.

20. Horwitz DA. "Impaired delayed hypersensitivity in systemic lupus erythematosus. " Arthritis Rheum. 1972; 15: 353 - 9.

21. Charpentier B, Carnoud C, Bach JF. "Selective depression of the xenogeneic cell mediated lympholysis in systemic lupus erythematosus. " J Clin Invest. 1979; 64: 351 - 60.

22. Stohl W. "Impaired generation of polyclonal T cell-mediated cytolytic activity "


88

"despite normal polyclonal T cell proliferation in systemic lupus erythematosus. " Clin Immunol Immunopathol. 1992. 63: 163 - 72.

23. Cohen PL, Litvin DA, Winfield JB. "Association between endogenously activated T cells and immunoglobulin-secreting B cells in patients with active systemic lupus erythematosus. " Arthritis Rheum. 1982; 25: 168 - 73.

24. Gharavi AE, Chu J-L, Elkon KB. "Autoantibodies to intracellular proteins in human systemic lupus erythematosus. " Arthritis Rheum. 1988; 31: 1337 - 45.

25. Rajagopalan S, Zordan T, Tsokos GC, Datta SK. "Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: Isolation of CD4-8-T helper cell lines that express that theta delta T cell antigen receptor. " Proc Natl Acad Sci USA. 1990; 87: 7020 - 4.

26. Linker-Israeli M, Quismorio FP Jr, Horwitz DA. "CD8+ lymphocytes from patients with systemic lupus erythematosus sustain rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support antibody synthesis. " Arthritis Rheum. 1990; 33: 1216 - 25.

27. Portales-Peres D et al. "Abnormalities in CD69 expression,cytosolic ph and Ca2+ during activation of lymphocytes from patients with sysremic lupus erythematosus. " Lupus. 1997; 6: 48 - 56.

28. Raziuddin S, al-Jandi MA, Alwabel AA. "T-cell receptor alpha/beta chain-CD3 Protein complex defect in systemic lupus erythematosus: T-cell function. " Am J Med. 1992; 93: 461 - 6.

29. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. "Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. " J Clin Invest. 1996; 97: 2063 - 73.

30. ter Borg EJ, Horst G, Hummel EJ et al. " " Measurement of increase in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum. 1990; 33: 634 - 43.


89

31. Guilbert B, Dighiero G, Avrameas S. "Naturally occuring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. " J Immunol. 1982; 128: 2779 - 87.

32. Gaillard RC. "Neuroendocrine-immune system interactions. The immune hypothalamo-pituitary-adrenal axis. " Trends in endocrinology and metabolism. 1994; Vol.5, Nr.7: 303 - 9.

33. Estes D, Christian CL. "The natural history of systemic lupus erythematosus by prospective analysis. " Medicine (Baltimore). 1971; 50: 85 - 95.

34. Deapen D et al. "A revised estimate of twin concordance in systemis lupus erythematosus. " Arthritis Rheum. 1992; 35: 311 - 8.

35. Schur PH, Sandson J. "Immunologic factors and clinical activity in systemic lupus erythematosus. " New Engl J Med. 1968; 278: 533.

36. Sabbatini A, Bombardieri S, Migliorini P. "Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA 1. " Eur J Immunol. 1993; 23: 1146 - 52.

37. Granholm NA, Cavallo T. "Autoimmunity, polyclonal B cell activation and infection. " Lupus. 1992; 1: 63 - 74.

38. Lahita RG. "Sex and age in systemic lupus erythematosus. In: Systemic Lupus Erythematosus;" Wiley, New York. 1986; 523 - 39.

39. Kanda N et al. "Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. " Arthritis Rheum. 1997; 40: 1703 - 11.

40. Suzuki T, Suzuki N, Engelman EG, Mizushima Y, Sakane T. "Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE). " Clin Exp Immunol. 1995; 99: 251 - 5.

41. Dayan M, Zinger H, Kalush F et al. "The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. " Immunology.


90

1997; 90: 101 - 8.

42. Nicoll CS. Physiological actions of prolactin. In: Handbook of physiology, section 7: Endocrinology Vol IV, part 2, Washington, DC. 1974; 253 - 92.

43. Stricker P, Grueter R. "Action du lobe anterieur de l´hypophyse sur la montee laiteuse. " Compt Rend Soc Biol (Paris). 1928; 99: 1978 - 80.

44. Riddle O, Bates RW, Dykshorn SW. "A new hormone of the anterior pituitary. " Proc Soc Exp Biol Med. 1932; 29: 1212 - 5.

45. Lewis UJ, Singh RNP, Seavey BK. "Human prolactin: Isolation and some properties. " Biochem Biophys Res Commun. 1971; 44: 1169 - 76.

46. Cooke NE, Coit D, Weiner RI et al. "Structure of cloned DNA complementary to rat prolactin messenger RNA. " J Biol Chem. 1980; 255: 6502 - 10.

47. Rosenfeld MG. "POU-domain transcription factores: Pou-er-ful developmental regulators. " Genes Dev. 1991; 5: 897 - 907.

48. Kelly PA, Djiane J, Postel-Vinay MC, Edery M. "The prolactin /growth hormone receptor family. " Endocr Rev. 1991; 12: 235 - 51.

49. Sinha YN. "Prolactin variants. " Trends Endocrinol Metab. 1992; 3: 100 - 6.

50. Horseman ND, Yu-Lee LY. "Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin and hematopoetic cytokines. " Endocr Rev. 1994; 15: 627 - 49.

51. Owerbach D et al. "The prolactin gene is located on chromosome 6 in humans. " Science. 1981; 212: 815 - 6.

52. Miller WL, Eberhardt NL. "Structure and evolution of the growth hormone family. " Endocr Rev. 1983; 4: 97 - 130.

53. Sinha YN. "Structural variants of prolactin: occurrence and physiological significance. " Endocr Rev. 1995; 16: 354 - 69.

54. Powers CA, Hatala MA. "Prolactin proteolysis by glandular kallikrein: in vitro reaction requirements and cleavage sites, and detection of processed prolactin in vitro. " Endocrinology. 1990; 127: 1916 - 27.


91

55. Baldocchhi RA, Tan L, Nicoll CS. "Processing of rat prolactin by rat tissue explants and serum in vitro. " Endocrinology. 1992; 130: 1653 - 9.

56. Cohen H, Cohen O, Gagnon J. "Serum prolactin-binding protein (PRL-BP) of human and rat are identified as IgG. " C R Aca Sci III. 1994; 317: 293 - 8.

57. Bonhoff A, Vuille JC, Gomez F, Gellersen B. "Identification of macroprolactin in a patient with asymptomatic hyperprolactinemia as a stable PRL-IgG complex. " Exp Clin Endocrinol Diabetes. 1995; 103: 252 - 5.

58. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi H. "Effects of anti-prolactin autoantibodies on serum prolactin measurements. " Eur J Endocrinol. 1994; 130: 434 - 7.

59. Ben-Jonathan N et al. "Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. " Endocr Rev. 1996; 17: 639 - 69.

60. Jackson RD,Wortsman J, Malarkey WB. "Characterization of a large molecular weight prolactin in women with ideopathic hyperprolactinemia and normal menses. " J Clin Endocrinol Metab. 1985; 61: 258 - 64.

61. Carlson HE, Markhoff E, Lee DW. "On the nature of serum prolactin in two patients with makroprolactinemia. " Fertil Steril. 1992; 58: 78 - 87.

62. Hattori N, Ishihara T, Ikekubo K, Moridera K, Hino M, Kurahachi H. "Autoantibody to human prolactin in patients with ideopathic hyperprolactinemia. " J Clin Endocrinol Metab. 1992; 75: 1226 - 9.

63. Leite V, Cosby H, Sobrinho LG, Fresnoza A, Santos MA, Friesen HG. "Characterization of big, big prolactin in patients with hyperprolactinemia. " Clin Endocrinol (Oxf). 1992; 37: 365 - 72.

64. Walker AM et al. "Prolactin-immunglobulin G complexes from human act as costimulatory ligands causing proliferation of malignant B lymphocytes. " Proc Natl Acad Sci USA. 1995; 92: 3278 - 82.

65. Hattori N. "The frequency of makroprolactinemia in pregnant women and the heterogeneity of its etiologies. " J Clin Endocrinol Metab. 1996; 81: 586 - 90.


92

66. Hattori N et al. "Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody. " Eur J Endocrinol. 1994; 130: 438 - 45.

67. Clapp C, Sears PS, Nicoll CS. "Binding studies with intact rat prolactin and a 16K fragment of the hormone. " Endocrinology. 1989; 125: 1054 - 9.

68. Clapp C, Martial JA, Guzman RC et al. "The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. " Endocrinology. 1993; 133: 1292 - 9.

69. Clapp C, Weiner RI. "A specific high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. " Endocrinology. 1992; 130: 1380 - 6.

70. Anthony PK, Stoltz RA, Pucci ML, Powers CA. "The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules, and regulated release. " Endocrinology. 1993; 132: 806 - 14.

71. Nagy E, Berczi I. "Hypophysectomized rats depend on residual prolactin for survival. " Endocrinology. 1991; 128: 2776 - 84.

72. Leighton PC, NcNeilly AS, Chard T. "Short-term variation in blood levels of prolactin in women. " J Endocrinol. 1976; 68: 177 - 8.

73. Weitzman ED, Boyar RM, Kapen S, Hellmann L. "The relationship of sleep stages to neuroendocrine secretion and biological rhythm in man. " Recent Prog Horm Res. 1975. 31: 399 - 446.

74. Sievertsen GD, Lim VS, Nakawatase C, Frohman LA. "Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. " J Clin Endocrinol Metab. 1980; 50: 846 - 52.

75. Yamaji T, Shimamoto K, Ishibashi M et al. "Effect of age and sex on circulating and pituitary prolactin levels in humans. " Acta Endocrinol (Copenh). 1976; 83: 711 - 9.

76. Balint-Peric LA, Prelevic GM. "Changes in prolactin levels with the menopause. The effect of estrogen/androgen and calcitonin treatment. " Gynaecol Endosc. 1997; 6/4: 275 - 80.


93

77. Lyons A et al. "Pituitary dysfunction in recently post-menopausal women. Nottingham EPIC study group. " Clin Endocrinol Oxf. 1997; 47: 431 - 8.

78. Ehara Y, Siler T, VandenBerg G, Sinha YN, Yen SSC. "Circulating prolactin levels during the menstrual cycle: Episodic release and diurnal variation. " Am J Obstet Gynecol. 1973; 117: 962 - 70.

79. Veldhuis JD, Evans WS, Johnson MD, Stumpf PG. "Mechanisms that subserve estradiol`s induction of increased prolactin concentrations: Evidence of amplitude modulation of spontaneous prolactin secretory bursts. " Am J Obstet Gynecol. 1989; 161: 1149 - 58.

80. Maurer RA. "Estradiol regulates the transcription of the prolactin gene. " J Biol Chem. 1982. 257: 2133 - 6.

81. Lean AD, Garon M, Kelly PA, Labrie F. "Changes in pituitary thyrotropin releasing hormone (TRH) receptor level and prolactin response to TRH during the estrous cycle. " Endocrinology. 1977; 100: 1505 - 10.

82. Raymond V, Beaulieu M, Labrie F, Boissier J. "Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. " Science. 1978; 200: 1173 - 5.

83. Sprangers SA, Brenner AM, Bethea CL. "Estrogen and progestin receptor immunocytochemistry in lactotropes versus gonadotropes of monkey pituitary cell cultures. " Endocrinology. 1989; 124: 1462 - 70.

84. Rakoff JS, Yen SS. "Progesterone induced acute release of prolactin in estrogen primed ovariectomized women. " J Clin Endocrinol Metab. 1978; 47: 918 - 21.

85. Yen SSC. "Prolactin in human reproduction. In: Reproductive Endocrinology.3rd ed. " Philadelphia, USA; 1991; 357-388.

86. Noel GL, Dimond RC,Wartkofsky L et al. "Studies of prolactin and TSH secretion by continuous infusion of small amounts of thyrotropin releasing hormone (TRH). " J Clin Endocrinol Metab. 1974; 39: 6 - 17.

87. Nagy G, Mulchahey JJ, Neill JD. "Autocrine control of prolactin secretion by vasoactive intestinal peptide. " Endocrinology. 1988; 122: 364 - 6.


94

88. Ben-Jonathan N, Arbogast LA, Hyde JF. "Neuroendocrine regulation of prolactin release. " Prog Neurobiol. 1989; 33: 399 - 447.

89. Lim VS, Kathpalia S, Frohman LA. "Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: Reversal after transplantation. " J Endocrinol Metab. 1979; 48: 101 - 7.

90. Verbee len D, Vanhaelst L et al. "Effect of 1,25-dihydroxyvitamin D3 on plasma prolactin in patients with renal failure on regular dialysis treatment. " J Endocrinol Invest. 1983; 6: 359 - 62.

91. Stephanou A, Sarlis NJ, Knight RA, Lightman SL, Chowdrey HS. "Glucocorticoid-mediated responses of plasma ACTH and anterior pituitary proopiomelanocortin, growth hormone and prolactin mRNA during adjuvant induced arthritis in the rat. " Neuroendocrinology. 1992; 9: 273 - 81.

92. Tsigos C et al. "Dose effects of recombinant Interleukin-6 on pituitary hormone secretion and energy expenditure. " Neuroendocrinology. 1997; 66: 54 - 62.

93. Bryan L et al. "Interleukin-6 stimulates anterior pituitary hormone release in vitro. " Endocrinology. 1989; 125: 575 - 578.

94. Tyson JE et al. "Studies of prolactin secretion in human pregnancy. " Am J Obstet Gynecol. 1972; 113: 14 - 20.

95. Veldhuis JD, Evans WS, Johnson MD, Stumpf PG. "Mechanisms that subserve estradiol`s induction of increased prolactin concentrations: Evidence of amplitude modulation of spontaneous prolactin secretory bursts. " Am J Obstet Gynecol. 1989; 161: 1149 - 58.

96. Markhoff E, Lee DW, Hollingsworth DR. "Glycosylated and nonglycosylated prolactin in serum during pregnancy. " J Clin Endocrinol Metab. 1988; 67: 519 - 23.

97. Stier CT Jr, Cowden EA, Friesen HG, Allison MEM. "Prolactin and the rat kidney: A clearance and micropuncture study. " Endocrinology. 1984; 115: 362 - 7.

98. Hamosh M, Hamosh P. "The effect of prolactin on the lecithin content of fetal "


95

"rabbit lung. " J Clin Invest. 1977; 59: 1002 - 5.

99. Pullano JG et al. "Water and salt conservation in the human fetus and newborn. I. Evidence for role of fetal prolactin. " J Clin Endocrinol Metab. 1989; 69: 1180 - 6.

100. Dardenne M et al. "Neuroendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin by human and murine thymic epithelial cells. " Endocrinology. 1989; 125: 3 - 12.

101. Heffner LJ, Gramates LS, Yuan RW. "A glycosylated prolactin species is covalently bound to immunoglobulin in human amniotic fluid. " Biochem Biophys Res Comm. 1989; 165: 299 - 305.

102. McCoshen JA, Tomita K, Fernandez C, Tyson JE. "Specific cells of human amnion selectively localize prolactin. " J Clin Endocrinol Metab. 1982; 55: 166 - 9.

103. Lin B, Kinoshita Y, Hato F, Tsuji Y. "Enhancement of thymic lymphocyte proliferation by the culture supernatant of thymus epithelial cells stimulated by prolactin. " Cell Mol Biol Noisy le grand. 1997; 43: 361 - 7.

104. de Mello Coelho V, Villa Verde DM, Dardenne M, Savino W. "Pituitary hormones modulate cell-cell interactions between thymocytes and thymic epithelial cells. " J Neuroimmunol. 1997; 76: 39 - 49.

105. Ellis LA, Mastro AM, Picciano MF. "Do milk-borne cytokines and hormones influence neonatal immune cell function? " J Nutr. 1997; 127 (5 Suppl): 985 - 8.

106. Hattori N, Inagaki C. "Anti-prolactin autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunglobulin G complex. " J Clin Endocrinol Metab. 1997; 82: 3107 - 10.

107. Vance M L, Thorner M O. Prolactin: Hyperprolactinemic syndromes and management. In: Endocrinology. DeGroot LJ, Vol.I, 3rd ed. Philadelphia; 1995; 394 - 405.

108. Klibanski A, Neer R, Beitins I, Ridgway E, Mc-Arthur J. "Decreased bone density in hyperprolactinemic women. " N Engl J Med. 1981; 303: 1511 -


96

4.

109. Koppelmann MC et al. Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab. 1984; 59: 1050 - 3.

110. Pahuja DN, De Luca HF. Stimulation of intestinal calcium transport and bone calcium mobilization by prolactin in vitamin D-deficient rats. Science. 1981. 214: 1038 - 9.

111. Thorner MO, Edwards CRW, Hanker JP et al. "Prolactin and gonadotropin interaction in the male. " In: The testis in normal and infertile men. New York, Raven Press, 351 - 66.

112. Gustafson AB et al. "Correlation of hyperprolactinemia with altered plasma insulin and glucagon: Similarity to effects of late human pregnancy. " J Clin Endocrinol Metab. 1980; 51: 242 - 6.

113. Kelly PA, Djiane J,Postel-Vinay MC, Edery M. "The prolactin/growth hormone receptor family. " Endocr Rev. 1991; 12: 235 - 51.

114. Boutin J, Edery M et al. "Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. " Mol Endocrinol. 1989; 3: 1455 - 62.

115. Clevenger CV, Chang W et al. "Expression of prolactin and prolactin receptor in human breast carcinoma. " Am J Pathol. 1995; 146: 695 - 705.

116. Rui H, Lebrun JJ et al. "JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. " Endocrinology. 1994; 135: 1299 - 306.

117. Rao YP, Olson MD, Buckley DJ, Buckley AR. "Nuclear colocalization of prolactin and the prolactin receptor in rat Nb2 node lymphoma cells. " Endocrinology. 1993; 133: 3062 - 5.

118. Clevenger CV, Russell DH, Appasamy PM, Prystrowsky MB. "Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. " Proc Natl Acad Sci USA. 1990; 87: 6460 - 4.


97

119. Walsh RJ,Slaby FJ,Posner BI. "A receptor-mediated mechanism for the transport of prolactin from blood to cerebrospinal fluid. " Endocrinology. 1987; 120: 1846 - 50.

120. Mercado M, Baumann G. "A growth hormone/prolactin-binding protein in human milk. " J Clin Endocrinol Metab. 1994; 79: 1637 - 41.

121. Mc Coshen JA, Barc J. "Prolactin bioactivity following decidual synthesis and transport by amniochorion. " Am J Obstet Gynecol. 1985; 153: 217 - 23.

122. Campbell GS, Argetsinger LS et al. "Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. " Proc Natl Acad Sci USA. 1994; 91: 5232 - 6.

123. Gouilleux F, Moritz D, Humar M et al. "Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF-STAT5-like transcription factor. " Endocrinology. 1995; 136: 5700 - 8.

124. Clevenger CV, Torigoe T, Reed JC. "Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in T-cell line. " J Biol Chem. 1994; 269: 5559 - 65.

125. Fuh G et al. Rational design of potent antagonists to the human growth hormone receptor. " " Science. 1992; 256: 1677 - 80.

126. Pellegrini I, Lebrun JJ, Ali S, Kelly PA. "Expression of prolactin and its receptor in human lyphoid cells. " Mol Endocrinol. 1992; 6: 1023 - 31.

127. Montgomery DW et al. "Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin like-proteins. " Endocrinology. 1992; 131: 3019 - 26.

128. O`Neal KD, Montgomery DW, Truong TM, Yu-Lee LY. "Prolactin gene expression in human thymocytes. " Mol Cell Endocrinol. 1992; 87: 19 - 23.

129. Sabharwal P et al. "Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. " Proc Natl Acad Sci USA. 1992; 89: 7713 - 6.


98

130. DiMattia GE, Gellersen HG, Bohnet, Friesen HG. "A human B-lymphoblastoid cell line produces prolactin. " Endocrinology. 1988; 122: 2508 - 17.

131. Baglia LA, Cruz K, Shaw JE. "An Epstein-Barr-Virus-negative Burkitt lymphoma cell line (sfRamos) secretes a prolactin-like protein during continuous growth in serum-free medium. " Endocrinology. 1991; 128: 2266 - 72.

132. Matera L, Cutufia M, Geuna M et al. "Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line. " J Neuroimmunology. 1997; 79: 12 - 21.

133. Larrea F et al. "A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. " J Clin Endocrinol Metab. 1997; 82: 3664 - 9.

134. Gutiérrez MA et al. "Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. " Lupus. 1995; 4: 348 - 52.

135. Shiu RP et al. "Receptor mediated mitogenic action of prolactin in rat lymphoma cell line. " Endocrinology. 1983; 113: 159 - 65.

136. Russell DH et al. "Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding by cyclosporine. " Immunol. 1985; 134: 3027 - 31.

137. Matera L et al. "Prolactin receptors on large granular lymphocytes: dual regulation by cyclosporine A. " Brain Behav Immun. 1988; 2: 1 - 10.

138. Mukherjee P, Mastro AM, Hymer WC. "Prolactin induction of IL-2 Receptors on rat splenic lymphocytes. " Endocrinology. 1990; 126: 88 - 94.

139. Viselli SM, Stanek EM, Mukherjee P, Hymer WC, Mastro AM. "Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. " Endocrinology. 1991; 129: 983 - 90.

140. Matera G et al. "Role of PRL in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells. " Immunology. 1996;


99

89: 619 - 26.

141. Lahat N, Miller A, Shtiller R, Touby E. "Differential effects of prolactin upon activation and differentiation of human B lymphocytes. " J Neuroimmunol. 1993; 47: 35 - 40.

142. Athreya BH, Pletcher J, Zulian F, Weiner DB, Williams WV. "Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro. " Clin Immunol Immunpathol. 1993; 66: 201 - 11.

143. Russell DH, Larson DF, Cardon SB, Copeland JG. "Cyclosporine inhibites prolactin induction of ornithine decarboxylase in rat tissues. " Mol Cell Endocrinol. 1984; 35: 159 - 66.

144. Nishiguchi Y, Hibasami H, Komada Y, Sakurai M, Nakashima K. "Human promyelocytic cell line HL60 has the specific binding sites for prolactin and its ornithine decarboxylase, DNA synthesis and cellular proliferation are induced by prolactin. " Leuk Res. 1993; 17: 633 - 7.

145. Schwarz LA, Stevens AM, Hrachovy JA, Yu-Lee LY. "Interferon regulatory factor-1 is induceble by prolactin interleukin-2 and concanavalin A in T cells. " Mol Cell Endocrinol. 1992; 86: 103 - 10.

146. Li-Yuan Y. "Molecular actions of prolactin in the immune system. " PSEBM. 1997; 215: 35 - 52.

147. Gaufo GO, Diamond MC. "Prolactin increases CD4/CD8 cell ratio in thymus grafted congenitally athymic nude mice. " Proc Natl Acad Sci USA. 1996; 93: 4165 - 9.

148. Gutiérrez MA, Molina JF, Jara LJ et al. "Prolactin-induced immunoglobulin and and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. " Int Arch Allergy Immunol. 1996; 109: 229 - 35.

149. Kumar A, Singh SM, Sodhi A. "Effect of prolactin on nitric oxide and interleukin-1 production of murine peritoneal makrophages: Role of Ca2+ and protein kinase C. " Int J Immunopharmac. 1997; 19: 129 - 33.

150. Ortega E, Forner MA, Barriga C. "Effect of prolactin on the in vitro phagocytic "


100

"capacity of makrophages. " Comp Immun Microbiol Infect Dis. 1996; 19: 139 - 46.

151. Thorat SP, Thatte bUM, Pai N, Dahanukar SA. "Effect of prolactin on neutrophils and monocytes. " Acta Haematol. 1993; 89: 219 - 20.

152. Cesario TC et al. "Enhanced yields of gamma interferon in prolactin-treated human peripheral blood mononulear cells. " Proc Soc Exp Biol Med. 1994; 205: 89 - 95.

153. Chen Y, Johnson AG. "In vivo activation of macrophages by prolactin from young and aging mice. " Int J Immunopharmacol. 1993; 15: 39 - 45.

154. Matera L et al. "Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoral lymphokine-activated killer cells. " Immunology. 1996; 89: 619 - 26.

155. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. "Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. " J Rheumatol. 1994; 21: 843 - 50.

156. Buskila D et al. "Autoantibody profile in sera of women with hyperprolactinemia. " J Autoimmunol. 1995; 8: 415 - 24.

157. Krause I et al. "Anti-endothelial cell antibodies in the sera of hyperprolactinemic women. " Lupus. 1998; 7: 377 - 82.

158. Ferrari C, Boghen M et al. "Thyroid autoimmunity in hyperprolactinemic disorders. " Acta Endocrinol. 1983; 104: 34 - 41.

159. Nagy E, Berczi I. "Pituitary dependence of bone marrow function. " Br J Hematol. 1989; 71: 457 - 62.

160. Nagy E, Berczi I, Friesen HG. "Regulation of immunity in rats by lactogenic and growth hormones. " Acta Endocrinol. 1983; 102: 351 - 7.

161. Berczi I, Nagy E, Asa SL, Kovacs K. "Pituitary hormones and contact sensitivity in rats. " Allergy. 1983; 38: 325 - 30.

162. Nagy E, Berczi I, Wren GE, Asa SL, Kovacs K. "Immunomodulation by "


101

"bromocriptine. " Immunopharmacology. 1983; 6: 231 - 43.

163. Russell DH, Mills KT, Talamantes FJ, Bern HA. "Neonatal administration of prolactin antiserum alters the developmental pattern of T- and B-lymphocytes in the thymus and spleen of BALB/c female mice. " Proc Natl Acad Sci USA. 1988; 85: 7404 - 7.

164. Hiestand PC, Mekler P, Nordmann R, Grieder A, Permonngkol C. "Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. " Proc Natl Acad Sci USA. 1986; 83: 2599 - 603.

165. Bindoni M, Belluardo N, Liciarello S, Marchese AE, Cicirata F. "Growth of Yoshida ascites tumor in the rat after radiofrequency destruction of the tuberoinfundibular region of the hypothalamus. " Neuroendocrinology. 1980; 30: 88 - 93.

166. Cross RJ, Markesbery WR, Brooks WH, Roszman TL. "Hypothalamic-immune interactions: neuromodulation of natural killer activity by lesioning of the anterior hypothalamus. " Immunology. 1984; 51: 399 - 405.

167. Forni G, Bindoni M, Santoni A, Marchese N, Giovarelli M. "Radiofrequency destructions of the tuberoinfundibular region of the hypothalamus permanently abrogates NK cell activity in mice. " Nature. 1983; 306: 181 - 4.

168. Gerli R, Rambotti P et al. "Reduced number of natural killer cells in patients with pathological hyperprolactinemia. " Clin Exp Immunol. 1986; 64: 339 - 406.

169. Matera L, Cesano A, Bellone G, Oberhjoltzer E. "Modulatory effect of prolatin on the resting and mitogen induced activity of T, B, and NK lymphocytes. " Brain Behav Immun. 1992; 6: 409 - 17.

170. Vidaller A, Llorente L, Larrea F, Mendez JP, Alcocer-Varela J, Alarcon-Segovia D. "T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment. " Clin Immunol Immunopathol. 1986; 38: 337 - 43.


102

171. Blank M, Krause I, Buskila D et al. "Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. " Cell Immunol. 1995; 162: 114 - 22.

172. Hedner LP, Bynke G. "Endogenous iridocyclitis relieved during treatment with bromocriptine. " Am J Ophthalmol. 1985; 100: 618 - 9.

173. Lever EG, McKerron CG. "Auto-immune Addison´s disease associated with hyperprolactinaemia. " Clin Endocrinol. 1984; 21: 35 - 41.

174. Honegger J et al. "Lymphocytic and granulomatous hypophysitis: Experience with nine cases. " Neurosurgery. 1997; 40: 713 - 23.

175. Gutiérrez MA et al. "Hyperprolactinaemia in primary Sjogren´s syndrome. " Ann Rheum Dis. 1994; 53: 425 - 8.

176. Kucharz EJ et al. "High serum level of prolactin in patients with systemic sclerosis. " Clin Rheumatol. 1996; 15: 314.

177: Picco P et al. "Prolactin and interleukin 6 in prepubertal girls with juvenile chronic arthritis. " J Rheumatol. 1998; 25: 347 - 51.

178. Lavalle C et al. "Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. " J Rheumatol. 1987; 14: 268 - 72.

179. Jara LJ et al. "Hyperprolactinemia in systemic lupus erythematosus: Association with disease activity. " Am J Med Sci. 1992; 303: 222 - 6.

180. Mok CC, Lau CS, Tam SCF. "Prolactin profile in a cohort of chinese systemic lupus erythematosus patients. " Br J Rheumatol. 1997; 36: 986 - 9.

181. Huang CM, Chou CT. "Hyperprolactinemia in systemic lupus erythematosus. " Chung Hua I Hsueh Tsa Chih Taipei. 1997; 59: 37 - 47.

182. Jimena P et al. "Prolactin levels in patients with systemic lupus erythematosus: a case controlled study. " Lupus. 1998; 7: 383 - 6.

183. Neidhart M. "Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. " J Rheumatol. 1996; 23: 476 - 81.


103

184. Pauzner R, Urowitz MB, Gladman DD, Gough JM. "Prolactin in systemic lupus erythematosus. " J Rheumatol. 1994; 21: 2064 - 7.

185. Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. "No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. " J Rheumatol. 1996; 23: 629 - 32.

186. Munoz JA et al. "Sex hormones in chronic systemic lupus erythematosus. Correlation with clinical and biological parameters. " Ann de Med Intern. 1994; 145: 459 - 63.

187. Ostendorf B et al. "Hyperprolactinemia in systemic lupus erythematosus. " Scand J Rheumatol. 1996; 25: 97 - 102.

188. El-Graf A et al. "Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations. " J Rheumatol. 1996; 23: 374 - 7.

189. Miranda JM, Prieto RE et al. "Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. " Lupus. 1998; 7: 387 - 91.

190. Alvarez-Nemegyei J et al. "Bromocriptine in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled study. " Lupus. 1998. 7: 414 - 9.

191. McMurray RW, Weidensaul D, Allen SH, Walker SE. "Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. " J Rheumatol. 1995; 22: 2084 - 91.

192. McMurray RW, Hoffman RW, Walker SE. "In vivo prolactin manipulations alters in vitro IL-2, IL-4, and IFN mRNA levels in female B/W mice (abstr). " Arthritis Rheum. 1991; 39: 734A.

193. Tan EM, Cohen AS, Fries JF et al. "The 1982 revised criteria for the classification of systemic lupus erythematosus. " Arthritis Rheum. 1982; 25: 1271 - 7.

194. Müller P, Dammann HG, Simon B. "Mehrwöchige Gabe von Ranitidin einmal am Abend: Einfluß auf Säureverhalten und basale Hormonspiegel bei gesunden Probanden. " Arzneimittelforschung. 1985; 35: 1472 - 4.


104

195. Tanimoto K et al. "Classification criteria for polymyositis and dermatomyositis. " J Rheumatol. 1995; 22: 668 - 74.

196. Sharp GC et al. "Mixed connective tissue disease- an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). " Am J Med. 1972; 52: 148 - 59.

197. Vitali C et al. "Preliminary criteria for the classification of Sjögren´s syndrome. " Arthritis Rheum. 1993; 36: 340 - 6.

198. Masi AT et al. Perliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and therapeutic criteria Commitee. Arthritis Rheum. 1980; 23: 581 - 90.

199. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW et al. "The American College of Rheumatology, 1990 Criteria for the classification of Wegner´sche Granulomatosis. " Arthritis Rheum. 1990; 33: 1101 - 7.

200. Vitali C et al. "Disease activity in systemic lupus erythematosus: a report of the Consensus Study Group of the European Workshop for Rheum. Research.II. Identification of the variables indicative of disease activity and their use in the development of an activity score. " Clin Exp Rheumatol. 1992; 10: 541 - 7.

201. Boyum A. "Isolation of mononuclear cells and granulocytes from human blood. " Scand J Clin Lab Invest. 1968; 21: 77 - 98.

202. Takeuchi K, Turley SJ, Tan EM, Pollard KM. "Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity. " J Immunol. 1995; 154: 961 - 971.

203. D'Armiento M et al. "Lack of inhibition of anterior pituitary hormone release during chronic treatment with calcium antagonists. " Clin Endocrinol Oxf. 1984; 21: 233 - 7.

204. Jara LJ et al. "Prolactin and IL-6 in CSF of patient with SLE and CNS manifestations (abstr). " Arthritis Rheum. 1993; (suppl)37: 88.


105

205. Gutiérrez MA, Gracia ME, Rodriguez JA, Rivero S, Jacobelli S. "Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. " Lupus. 1998; 7: 404 - 8.

206. Rovenský J et al. "The hypothalamic-pituitary response in SLE. Regulation of prolactin, growth hormone and cortisol release. " Lupus. 1998; 7: 409 - 13.

207. Montgomery DW, LeFevre JA, Ulrich ED, Adamson CR, Zukoski CF. "Identification of prolactin like proteins synthesized by normal lymphocytes. " Endocrinology. 1990; 127: 2601 - 3.

208. Leanos A, Pascoe D, Fraga A, Blanco-Favela F. "Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia. " Lupus. 1998; 7: 398 - 403.

209. Rovenský J et al. "Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus. " J Rheumatol. 1997; 24: 2330 - 4.

210. Nalda AM, Martial JA, Muller M. "The glucocorticoid receptor inhibits the human prolactin gene expression by interference with pit-1 activity. " Mol Cell Endocrinol. 1997; 134: 129 - 37.

211. Leff MA et al. "Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. " Endocrinology. 1996; 137: 5456 - 62.

212. Fletcher-Chiappini SE et al. "Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: antiproliferative versus anticytolytic effects. " Proc Soc Exp Biol Med. 1993; 202: 345 - 52.

213. Clodi M, Svoboda T, Kotzmann H et al. "Effect of elevated serum prolactin concentrations on cytokine production and natural killer cell activity. " Neuroendocrinology. 1992; 56: 775 - 9.

214. Elbourne KB, Keisler D, McMurray RW. "Differetial effects of estrogen and prolactin on autoimmune diseasein the NZB/NZW F1 mouse model of systemic lupus erythematosus. " Lupus. 1998; 7: 420 - 7.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiML DTD Version 2.0
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Tue Sep 3 15:32:24 2002